Patents-Review.com
ClassID:

96979 ⎘

C07K14/565 - CPC Classification

Classification description:

Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans; Cytokines; Lymphokines; Interferons; Interferons [IFN] IFN-beta

Recent Application in this class:
#1
20260109748
2026-04-23

MODULATION OF DENDRITIC CELL LINEAGES

 #2
20260078349
2026-03-19

Enhanced adoptive cell therapy

 #3
20260035717
2026-02-05

ADENO-ASSOCIATED VIRAL VECTOR COMPOSITIONS AND METHODS OF USE

 #4
20260021149
2026-01-22

METHOD FOR TREATMENT OF TUMOR BY USING RECOMBINANT ONCOLYTIC VIRUS IN COMBINATION WITH SMALL-MOLECULE ANTICANCER DRUG

 #5
20260008830
2026-01-08

THERAPEUTIC CYTOKINES AND METHODS

 #6
20250361305
2025-11-27

PD-1 AND PD-L1 BINDING AGENTS

 #7
20250325634
2025-10-23

Fusion Protein Composition(s) Comprising Masked Type I Interferons (IFNa and IFNb) For Use in the Treatment of Cancer and Methods Thereof

 #8
20250320302
2025-10-16

INTERFERON-ASSOCIATED ANTIGEN BINDING PROTEINS FOR USE FOR THE TREATMENT OR PREVENTION OF CORONAVIRUS INFECTION

 #9
20250288662
2025-09-18

MULTIVALENT DISPLAY ON ENVELOPED PARTICLES WITH HUMAN OLIGOMERIZATION DOMAINS

 #10
20250276042
2025-09-04

METHOD FOR REDUCING FLU-LIKE SYMPTOMS ASSOCIATED WITH INTRAMUSCULAR ADMINISTRATION OF INTERFERON USING A FAST TITRATION ESCALATING DOSING REGIMEN

 #11
20250188143
2025-06-12

COMBINED GENE AND RADIO THERAPY FOR THE TREATMENT OF CANCER

 #12
20250186551
2025-06-12

THERAPEUTIC NUCLEIC ACID MOLECULE, MIXTURE, AND DRUG, AND USE THEREOF IN TREATING SOLID TUMOR

 #13
20250152643
2025-05-15

COMBINATIONS OF CHECKPOINT INHIBITORS AND ONCOLYTIC VIRUS FOR TREATING CANCER

 #14
20250074962
2025-03-06

MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF ONCOLOGY-RELATED PROTEINS AND PEPTIDES

 #15
20250057946
2025-02-20

USE OF INTERFERON AS AN ADJUVANT IN VACCINES

 #16
20250043008
2025-02-06

FUSION PROTEIN OF INTERFERON (IFN) AND ANTI-PD-L1 ANTIBODY AND USE THEREOF

 #17
20240425548
2024-12-26

ENGINEERED BACTERIAL RIBOSOME COMPOSITIONS AND METHODS

 #18
20240409597
2024-12-12

MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF SECRETED PROTEINS

 #19
20240368277
2024-11-07

SIRP1a TARGETED CHIMERIC PROTEINS AND USES THEREOF

 #20
20240352500
2024-10-24

INCREASE OF PROTEIN EXPRESSION AND SECRETION BY ARTIFICIAL CO-EXPRESSION OF HDLBP/VIGILIN

 #21
20240327476
2024-10-03

MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF PROTEINS ASSOCIATED WITH HUMAN DISEASE

 #22
20240299543
2024-09-12

SELF-POLARIZING IMMUNE CELLS

 #23
20240270807
2024-08-15

RECOMBINANT PROTEIN HAVING FUSED INTERFERON-BETA MUTEIN AND ANTIBODY, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME

 #24
20240269188
2024-08-15

METHODS FOR INDUCING AN IMMUNE RESPONSE BY ADMINISTERING ACTIVATED MESENCHYMAL STEM CELLS

 #25
20240228587
2024-07-11

IMMUNOGLOBULIN FUSION PROTEINS AND USES THEREOF

 #26
20240199750
2024-06-20

MULTISPECIFIC PROTEINS COMPRISING AN NKP46-BINDING SITE, A CANCER ANTGIENGE BINDING SITE FUSED TO A CYTOKINE FOR NK CELL ENGAGING

 #27
20240190935
2024-06-13

COMPOSITIONS AND METHODS OF TREATING PATHOGENIC INFECTIONS BY USING FUSION PROTEINS

 #28
20240189423
2024-06-13

BISPECIFIC BINDING AGENT-LIGAND FUSIONS FOR THE DEGRADATION OF TARGET PROTEINS

 #29
20240182545
2024-06-06

IMMUNOGLOBULIN FUSION PROTEINS

 #30
20240132572
2024-04-25

IMMUNOGLOBULIN FUSION PROTEINS AND USES THEREOF

 #31
20240124546
2024-04-18

MASKED ACTIVATABLE CYTOKINE CONSTRUCTS AND RELATED COMPOSITIONS AND METHOD

 #32
20240083966
2024-03-14

VESICULAR STOMATITIS VIRUSES

 #33
20240043492
2024-02-08

Compositions and Methods of Treating a Coronavirus Infection By Use of an Interferon Fusion Protein

 #34
20240026312
2024-01-25

PURIFICATION OF PROTEINS WITH CATIONIC SURFACTANT

 #35
20230365703
2023-11-16

BISPECIFIC RECOMBINANT PROTEIN AND USE THEREOF

 #36
20230331769
2023-10-19

METHOD FOR EXTENDING HALF-LIFE OF A PROTEIN

 #37
20230295304
2023-09-21

PD-1 AND PD-L1 BINDING AGENTS

 #38
20230295284
2023-09-21

ENHANCED-AFFINITY ANTI-ECM NANOBODY-CYTOKINE FUSIONS AND THEIR APPLICATIONS

 #39
20230250132
2023-08-10

METHOD FOR EXTENDING HALF-LIFE OF A PROTEIN

 #40
20230242577
2023-08-03

METHOD FOR EXTENDING HALF-LIFE OF A PROTEIN

 #41
20230242576
2023-08-03

METHOD FOR EXTENDING HALF-LIFE OF A PROTEIN

 #42
20230242575
2023-08-03

METHOD FOR EXTENDING HALF-LIFE OF A PROTEIN

 #43
20230242574
2023-08-03

METHOD FOR EXTENDING HALF-LIFE OF A PROTEIN

 #44
20230242573
2023-08-03

METHOD FOR EXTENDING HALF-LIFE OF A PROTEIN

 #45
20230183308
2023-06-15

PROPROTEINS AND METHODS OF USE THEREOF

 #46
20230159605
2023-05-25

HUMAN INTERFERON-BETA VARIANT WITH DOUBLE MUTATION AND METHOD FOR IMPROVING STABILITY OF HUMAN INTERFERON-BETA VARIANT

 #47
20230041904
2023-02-09

METHOD FOR ENHANCING WATER SOLUBILITY OF TARGET PROTEIN BY WHEP DOMAIN FUSION

 #48
20230035290
2023-02-02

PROPROTEINS AND METHODS OF USE THEREOF

 #49
20230023927
2023-01-26

IMMUNOGLOBULIN CHIMERIC MONOMER-DIMER HYBRIDS

 #50
20230002493
2023-01-05

PD-L1 TARGETED CHIMERIC PROTEINS AND USES THEREOF

 #51
20220389423
2022-12-08

Compositions and Methods for Simultaneously Modulating Expression of Genes

 #52
20220332844
2022-10-20

FIBROBLAST ACTIVATION PROTEIN BINDING AGENTS AND USE THEREOF

 #53
20220323521
2022-10-13

Compositions and Uses for Engineered Therapeutic Microbes and Associated Receptors

 #54
20220306717
2022-09-29

Masked activatable interferon constructs

 #55
20220288222
2022-09-15

USE OF IMMUNOCYTOKINE COMPRISING INTERFERON-BETA OR VARIANT THEREOF FOR TREATING HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2 POSITIVE CANCER

 #56
20220280610
2022-09-08

METHOD FOR REDUCING FLU-LIKE SYMPTOMS ASSOCIATED WITH INTRAMUSCULAR ADMINISTRATION OF INTERFERON USING A FAST TITRATION ESCALATING DOSING REGIMEN

 #57
20220259260
2022-08-18

METHOD FOR PURIFYING DIGLYCOSYLATED INTERFERON-BETA PROTEIN

 #58
20220185857
2022-06-16

FMS-LIKE TYROSINE KINASE 3 LIGAND (FLT3L)-BASED CHIMERIC PROTEINS

 #59
20220175912
2022-06-09

Immunopotentiator, immunotherapeutic pharmaceutical composition and its preparation and use

 #60
20220133876
2022-05-05

NOVEL RECOMBINANT INFLUENZA VIRUS HAVING IMMUNE AND THERAPEUTIC RESPONSES TO HETEROLOGOUS INFLUENZA A VIRUS, AND GENETIC VECTOR AND THERAPEUTIC VACCINE COMPRISING SAME

 #61
20220119824
2022-04-21

IMMUNOSTIMULATORY BACTERIA-BASED VACCINES, THERAPEUTICS, AND RNA DELIVERY PLATFORMS

 #62
20220119519
2022-04-21

SIRP1α targeted chimeric proteins and uses thereof

 #63
20220119472
2022-04-21

MODULATION OF DENDRITIC CELL LINEAGES

 #64
20220089668
2022-03-24

TARGETED MUTANT INTERFERON-BETA AND USES THEREOF

 #65
20220073886
2022-03-10

PURIFICATION OF PROTEINS WITH CATIONIC SURFACTANT

 #66
20220023338
2022-01-27

COMPOSITIONS AND METHODS RELATED TO TUMOR CELL KILLERS AND VACCINES

 #67
20220010000
2022-01-13

IMMUNOGLOBULIN CHIMERIC MONOMER-DIMER HYBRIDS

 #68
20210340273
2021-11-04

5T4 SINGLE DOMAIN ANTIBODIES AND THERAPEUTIC COMPOSITIONS THEREOF

 #69
20210269823
2021-09-02

GENETICALLY-MODIFIED POULTRY EGG

 #70
20210236558
2021-08-05

Methods for inducing an immune response by administering activated mesenchymal stem cells

 #71
20210213067
2021-07-15

Methods of administering mesenchymal stem cells activated by cytokines for enhancing immunosuppression

 #72
20210177983
2021-06-17

SINGLE CHAIN Fc FUSION PROTEINS

 #73
20210147548
2021-05-20

Fusion protein of interferon (IFN) and anti-PD-L1 antibody and use thereof

 #74
20210130404
2021-05-06

PEPTIDE TAG AND TAGGED PROTEIN INCLUDING SAME

 #75
20210115101
2021-04-22

MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF PROTEINS ASSOCIATED WITH HUMAN DISEASE

 #76
20210052727
2021-02-25

Cytokine fusion proteins

 #77
20210024631
2021-01-28

BI-FUNCTIONAL PROTEINS AND CONSTRUCTION THEREOF

 #78
20210024614
2021-01-28

Aldehyde Tags, Uses Thereof in Site-Specific Protein Modification

 #79
20210009720
2021-01-14

HUMAN INTERFERON-BETA VARIANT CONJUGATED IMMUNOCYTOKINE AND METHOD FOR PREPARING SAME

 #80
20200407448
2020-12-31

PD-1 and PD-L1 binding agents

 #81
20200399615
2020-12-24

Enhanced adoptive cell therapy

 #82
20200354423
2020-11-12

MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF SECRETED PROTEINS

 #83
20200345775
2020-11-05

Method of treating glioblastoma multiforme

 #84
20200325204
2020-10-15

Vesicular stomatitis viruses

 #85
20200308243
2020-10-01

PROPROTEINS AND METHODS OF USE THEREOF

 #86
20200299333
2020-09-24

Engineered bacterial ribosome compositions and methods

 #87
20200283498
2020-09-10

T CELL RECEPTOR FUSIONS AND CONJUGATES AND METHODS OF USE THEREOF

 #88
20200247861
2020-08-06

MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF ONCOLOGY-RELATED PROTEINS AND PEPTIDES

 #89
20200172594
2020-06-04

T CELL RECEPTOR FUSIONS AND CONJUGATES AND METHODS OF USE THEREOF

 #90
20200131239
2020-04-30

Methods and compositions for promoting immune cell function

 #91
20200123227
2020-04-23

INTERFERON PRODRUG FOR THE TREATMENT OF CANCER

 #92
20200071385
2020-03-05

Immunoglobulin chimeric monomer-dimer hybrids

 #93
20200071375
2020-03-05

Type I and type III interferon fusion molecules and methods for use thereof

 #94
20200069773
2020-03-05

IL-10 EGFR antibody fusion protein and uses thereof

 #95
20200056160
2020-02-20

PURIFICATION OF PROTEINS WITH CATIONIC SURFACTANT

 #96
20200048321
2020-02-13

PANTIDS FOR TREATMENT OF AUTOIMMUNE DISORDERS

 #97
20200046804
2020-02-13

METHOD FOR REDUCING FLU-LIKE SYMPTOMS ASSOCIATED WITH INTRAMUSCULAR ADMINISTRATION OF INTERFERON USING A FAST TITRATION ESCALATING DOSING REGIMEN

 #98
20200017876
2020-01-16

COMPOSITION FOR INCREASING EXPRESSION LEVEL OF INTERFERON IN ANIMAL CELLS USING PLANT-DERIVED DNA DEMETHYLASE, ANTIVIRAL COMPOSITION, AND METHOD USING SAME

 #99
20200017565
2020-01-16

Modified polynucleotides for the production of secreted proteins

 #100
20190382439
2019-12-19

METHOD FOR EXTENDING HALF-LIFE OF A PROTEIN

 #101
20190315824
2019-10-17

Modified polynucleotides for the production of secreted proteins

 #102
20190270787
2019-09-05

CYSTEINE VARIANTS OF INTERLEUKIN-11 AND METHODS OF USE THEREOF

 #103
20190194284
2019-06-27

Targeted mutant interferon-beta and uses thereof

 #104
20190153070
2019-05-23

Aldehyde tags, uses thereof in site-specific protein modification

 #105
20190135939
2019-05-09

Anti-CSPG4 fusions with interferon for the treatment of malignancy

 #106
20190092832
2019-03-28

Interferon-beta analog peptide

 #107
20190046577
2019-02-14

Methods of producing activated mesenchymal stem cells

 #108
20190024094
2019-01-24

Peptide tag and tagged protein including same

 #109
20190010515
2019-01-10

Genetically modified chicken egg with an exogenous sequence knocked into the ovalbumin gene

 #110
20180362609
2018-12-20

IFN beta protein analogs

 #111
20180344876
2018-12-06

Vectors Conditionally Expressing Protein

 #112
20180312561
2018-11-01

FOCUSED INTERFERON IMMUNOTHERAPY FOR TREATMENT OF CANCER

 #113
20180289825
2018-10-11

Single chain Fc fusion proteins

 #114
20180271921
2018-09-27

Modified oncolytic vaccinia viruses expressing a cytokine and a car-boxylesterase and methods of use thereof

 #115
20180237492
2018-08-23

Vesicular stomatitis viruses

 #116
20180236092
2018-08-23

Human interferon-beta variant conjugated immunocytokine and method for preparing same

 #117
20180170990
2018-06-21

MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF NUCLEAR PROTEINS

 #118
20180162948
2018-06-14

CD138-targeted interferon demonstrates potent apoptotic and anti-tumor activities

 #119
20180086807
2018-03-29

MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF PROTEINS ASSOCIATED WITH HUMAN DISEASE

 #120
20180037604
2018-02-08

PROCESS FOR THE PURIFICATION OF RECOMBINANT PROTEINS

 #121
20180030127
2018-02-01

Method of preparing an anti-serum albumin Fab-effector moiety fusion construct

 #122
20180002393
2018-01-04

Modified polynucleotides for the production of oncology-related proteins and peptides

 #123
20170369547
2017-12-28

Method to increase the number of circulating platelets by administering PEGylated cysteine variants of IL-11

 #124
20170360890
2017-12-21

Method for reducing flu-like symptoms associated with intramuscular administration of interferon using a fast titration escalating dosing regimen

 #125
20170340708
2017-11-30

Proteinaceous heterodimer and use thereof

 #126
20170327786
2017-11-16

Hypotaurine, GABA, Beta-Alanine, and Choline for Control of Waste Byproduct Accumulation in Mammalian Cell Culture Process

 #127
20170320933
2017-11-09

Cytokine-based fusion proteins for treatment of immune disorders

 #128
20170312358
2017-11-02

Cytokines and neuroantigens for treatment of immune disorders

 #129
20170266309
2017-09-21

Immunoglobulin chimeric monomer-dimer hybrids

 #130
20170246254
2017-08-31

Lyophilised pharmaceutical formulation and its use

 #131
20170240608
2017-08-24

Cleavage-activatable interferon-alpha proprotein

 #132
20170233449
2017-08-17

Fusions of antibodies to CD38 and attenuated interferon alpha

 #133
20170232111
2017-08-17

Pegylation method

 #134
20170226189
2017-08-10

Immunoglobulin chimeric monomer-dimer hybrids

 #135
20170209588
2017-07-27

PEGylated interferon-beta variant

 #136
20170166873
2017-06-15

PURIFICATION OF PROTEINS WITH CATIONIC SURFACTANT

 #137
20170151342
2017-06-01

Targeted interferons demonstrate potent apoptotic and anti-tumor activities

 #138
20170145068
2017-05-25

NOVEL IFN BETA PROTEIN ANALOGS

 #139
20170137786
2017-05-18

Enhanced adoptive cell therapy

 #140
20170121389
2017-05-04

Aldehyde tags, uses thereof in site-specific protein modification

 #141
20170096472
2017-04-06

ALBUMIN FUSION PROTEINS

 #142
20170051255
2017-02-23

Vesicular stomatitis viruses

 #143
20170028085
2017-02-02

MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF NUCLEAR PROTEINS

 #144
20160376350
2016-12-29

Anti-serum albumin Fab-effector moiety fusion construct, and a method of preparing the construct

 #145
20160375134
2016-12-29

Modified polynucleotides for the production of secreted proteins

 #146
20160362474
2016-12-15

Immunoglobulin fusion proteins and uses thereof

 #147
20160362473
2016-12-15

IMMUNOGLOBULIN FUSION PROTEINS AND USES THEREOF

 #148
20160340435
2016-11-24

Molecular constructs for treating central nervous system diseases

 #149
20160340427
2016-11-24

Molecular constructs for treating infectious diseases

 #150
20160339116
2016-11-24

Molecular constructs with targeting and effector moieties for treating infectious diseases

 #151
20160339115
2016-11-24

Molecular constructs with targeting and effector moieties comprising an SCFV specific for ectodomain of transferrin-1 receptor and fingolimod

 #152
20160339111
2016-11-24

Peptide core-based multi-arm linkers for treating infectious diseases

 #153
20160339110
2016-11-24

Peptide core-based multi-arm linkers for treating central nervous system diseases

 #154
20160339109
2016-11-24

Peptide core-based multi-arm linkers and their applications

 #155
20160243216
2016-08-25

CMV IMMUNO-STIMULATORY COMPOSITION

 #156
20160237108
2016-08-18

Polynucleotide molecules and uses thereof

 #157
20160175458
2016-06-23

SINGLE CHAIN FC FUSION PROTEINS

 #158
20160152687
2016-06-02

ALBUMIN FUSION PROTEINS

 #159
20160115242
2016-04-28

Anti-CSPG4 fusions with interferon for the treatment of malignancy

 #160
20160115239
2016-04-28

CD138-targeted interferon demonstrates potent apoptotic and anti-tumor activities

 #161
20160052987
2016-02-25

Polypeptide having sialylated sugar chains attached thereto

 #162
20160002285
2016-01-07

THERAPEUTIC PROTEIN COMPOSITIONS HAVING REDUCED IMMUNOGENICITY AND/OR IMPROVED EFFICACY

 #163
20150368665
2015-12-24

Modified polynucleotides for the production of secreted proteins

 #164
20150366944
2015-12-24

INTERFERON TREATMENT TARGETING MUTANT P53 EXPRESSING CELLS

 #165
20150329619
2015-11-19

Albumin fusion proteins

 #166
20150274797
2015-10-01

Antibody Fusion Proteins with a Modified FcRn Binding Site

 #167
20150232880
2015-08-20

Enhanced adoptive cell therapy

 #168
20150203568
2015-07-23

Albumin fusion proteins

 #169
20150203559
2015-07-23

Soluble notch receptor proproteins and methods of use thereof

 #170
20150139947
2015-05-21

Immunoglobulin chimeric monomer-dimer hybrids

 #171
20150104414
2015-04-16

Cytokines and neuroantigens for treatment of immune disorders

 #172
20150093359
2015-04-02

Stable liquid interferon beta formulations

 #173
20150072398
2015-03-12

Aldehyde tags, uses thereof in site-specific protein modification

 #174
20140369964
2014-12-18

Glycosylated polypeptide and pharmaceutical composition containing same

 #175
20140322132
2014-10-30

Fragments of p97 and uses thereof

 #176
20140308247
2014-10-16

Vectors conditionally expressing protein

 #177
20140255345
2014-09-11

Amino acid substituted molecules

 #178
20140248238
2014-09-04

Fusions of antibodies to CD38 and attenuated interferon alpha

 #179
20140163204
2014-06-12

DERIVATIVES OF GROWTH HORMONE AND RELATED PROTEINS

 #180
20140162318
2014-06-12

Enhancing ingredients for protein production from various cells

 #181
20140079668
2014-03-20

Targeted interferons demonstrating potent apoptotic and anti-tumor activities

 #182
20140030225
2014-01-30

Method of treatment using cysteine mutants of beta interferon

 #183
20140005361
2014-01-02

FC-Interferon-Beta Fusion Proteins

 #184
20130253170
2013-09-26

Hyaluronic acid-protein conjugates and method for preparing same

 #185
20130251681
2013-09-26

Vesicular stomatitis viruses

 #186
20130171138
2013-07-04

Immunoglobulin chimeric monomer-dimer hybrids

 #187
20130129679
2013-05-23

Interferon beta as antibacterial agents

 #188
20130064792
2013-03-14

Therapy for influenza like illness

 #189
20130058895
2013-03-07

High Pressure Treatment of Aggregated Interferons

 #190
20130028867
2013-01-31

Long-acting interferon beta formulation comprising an immunoglobulin fragment

 #191
20120309939
2012-12-06

Production of Therapeutic Proteins in Photosynthetic Organisms

 #192
20120276042
2012-11-01

Methods of use for cysteine variants of human G-CSF

 #193
20120237479
2012-09-20

Method for reducing flu-like symptoms associated with intramuscular administration of interferon using a fast titration escalating dosing regimen

 #194
20120197006
2012-08-02

Modified interferon beta polypeptides and their uses

 #195
20120177603
2012-07-12

METHOD FOR THE PURIFICATION OF INTERFERON-B

 #196
20120129218
2012-05-24

Cofilin knockdown host cells and uses thereof

 #197
20120082644
2012-04-05

CYTOKINES AND NEUROANTIGENS FOR TREATMENT OF IMMUNE DISORDERS

 #198
20120070406
2012-03-22

Method for reducing immunogenicity of therapeutic protein compositions

 #199
20120046240
2012-02-23

Method of Producing Hydroxyalkyl Starch Derivatives

 #200
20120046221
2012-02-23

Albumin fusion proteins

 #201
20110305669
2011-12-15

Process for the preparation of glycosylated interferon beta

 #202
20110287041
2011-11-24

Aldehyde tags, uses thereof in site-specific protein modification

 #203
20110263517
2011-10-27

Cytokines and Cytokine Receptors with Reduced Immunogenicity

 #204
20110250704
2011-10-13

Aldehyde tags, uses thereof in site-specific protein modification

 #205
20110250169
2011-10-13

Cysteine variants of interferon gamma

 #206
20110243966
2011-10-06

SINGLE CHAIN Fc (ScFc) REGIONS, BINDING POLYPEPTIDES COMPRISING SAME, AND METHODS RELATED THERETO

 #207
20110182919
2011-07-28

Immunoglobulin chimeric monomer-dimer hybrids

 #208
20110172165
2011-07-14

MODIFIED LINKERS

 #209
20110165122
2011-07-07

METHOD FOR TARGETED AND SUSTAINED ANTIVIRAL THERAPY

 #210
20110159540
2011-06-30

Methods for Chemically Synthesizing Immunoglobulin Chimeric Proteins

 #211
20110104112
2011-05-05

Interferon-antibody fusion proteins demonstrating potent apoptotic and anti-tumor activities

 #212
20110070191
2011-03-24

T CELL RECEPTOR FUSIONS AND CONJUGATES AND METHODS OF USE THERE OF

 #213
20110054152
2011-03-03

Hydroxyalkyl starch derivatives

 #214
20110020925
2011-01-27

NEW MODULATING MOLECULES FOR AN IMPROVED REGULATED EXPRESSION SYSTEM

 #215
20110009312
2011-01-13

Albumin fusion proteins

 #216
20110008289
2011-01-13

HYPERGLYCOSYLATED POLYPEPTIDE VARIANTS AND METHODS OF USE

 #217
20110008283
2011-01-13

INTERFERON FUSION PROTEINS

 #218
20100317609
2010-12-16

Method of Producing Hydroxyalkyl Starch Derivatives

 #219
20100297076
2010-11-25

Interferon-antibody fusion proteins demonstrating potent apoptotic and anti-tumor activities

 #220
20100285014
2010-11-11

IMMUNOGLOBULIN FUSION PROTEINS

 #221
20100273978
2010-10-28

Modified polypeptides suitable for acceptace of amino acid substited molecules

 #222
20100272720
2010-10-28

Antibody fusion proteins with a modified FcRn binding site

 #223
20100266529
2010-10-21

Methods of use of G-CSF cysteine muteins

 #224
20100254943
2010-10-07

Modified human interferon-beta polypeptides

 #225
20100249381
2010-09-30

Method for Purifying FC-Fusion Proteins

 #226
20100239531
2010-09-23

Methods of treating multiple sclerosis with stable liquid interferon-beta formulations

 #227
20100239529
2010-09-23

PEG-interferon-beta formulations

 #228
20100221212
2010-09-02

Protease activatable interferon alpha proprotein

 #229
20100172868
2010-07-08

Interferon-antibody fusion proteins demonstrating potent apoptotic and anti-tumor activities

 #230
20100145017
2010-06-10

Method of producing an interferon-β complex

 #231
20100143889
2010-06-10

RHABDOVIRIDAE VIRUS PREPARATIONS

 #232
20100092430
2010-04-15

ATTENUATED ONCOLYTIC PARAMYXOVIRUSES ENCODING AVIAN CYTOKINES

 #233
20100055070
2010-03-04

Cytokine-based fusion proteins for treatment of multiple sclerosis

 #234
20100003721
2010-01-07

Human interferon-beta mutein

 #235
20090317889
2009-12-24

Purification of proteins with cationic surfactant

 #236
20090311216
2009-12-17

RECOMBINANT INTERFERON-BETA WITH ENHANCED BIOLOGICAL ACTIVITY

 #237
20090291063
2009-11-26

Compositions and methods for the treatment of viral hepatitis

 #238
20090286958
2009-11-19

INTERFERON-BETA FUSION PROTEINS AND USES

 #239
20090263355
2009-10-22

DEAMIDATED INTERFERON-BETA

 #240
20090258832
2009-10-15

Cytokines and Cytokine Receptors With Reduced Immunocencity

 #241
20090253170
2009-10-08

Nucleotide sequences for regulating gene expression in plant trichomes and constructs and methods utilizing same

 #242
20090252729
2009-10-08

Single-chain Fc (scFc) regions, binding polypeptides comprising same, and methods related thereto

 #243
20090215121
2009-08-27

Process for preparing high levels of interferon beta

 #244
20090208454
2009-08-20

Modified interferon beta polypeptides and their uses

 #245
20090208453
2009-08-20

High pressure treatment of aggregated interferons

 #246
20090191154
2009-07-30

Stabilization of Fc-interferon-beta fusion proteins

 #247
20090123424
2009-05-14

Methods of interferon-β purification and recovery

 #248
20090099073
2009-04-16

Albumin Fusion Proteins

 #249
20090093402
2009-04-09

Albumin Fusion Proteins

 #250
20090060863
2009-03-05

DERIVATIVES OF GROWTH HORMONE AND RELATED PROTEINS

 #251
20090054628
2009-02-26

METHOD AND SYSTEM FOR IN VITRO PROTEIN FOLDING

 #252
20090043076
2009-02-12

Modified interferon beta with reduced immunogenicity

 #253
20090030183
2009-01-29

Interferon Beta-Like Molecules

 #254
20080317713
2008-12-25

Cysteine variants of interferon gamma

 #255
20080249288
2008-10-09

Methods for chemically synthesizing immunoglobulin chimeric proteins

 #256
20080219952
2008-09-11

Process For the Preparation of Glycosylated Interferon Beta

 #257
20080219950
2008-09-11

Cysteine variants of interferon-gamma

 #258
20080214439
2008-09-04

AMINO ACID SUBSTITUTED MOLECULES

 #259
20080213886
2008-09-04

Albumin fusion proteins

 #260
20080200641
2008-08-21

Methods of modifying polypeptides comprising non-natural amino acids

 #261
20080187956
2008-08-07

Aldehyde tags, uses thereof in site-specific protein modification

 #262
20080167240
2008-07-10

Albumin Fusion Proteins

 #263
20080167239
2008-07-10

Albumin fusion proteins comprising insulin polypeptides

 #264
20080161544
2008-07-03

Chromatographic separation of therapeutic polypeptides

 #265
20080161243
2008-07-03

Albumin Fusion Proteins

 #266
20080153751
2008-06-26

G-CSF-albumin fusion proteins

 #267
20080146503
2008-06-19

Albumin fusion proteins

 #268
20080125347
2008-05-29

Modified human interferon-β polypeptides

 #269
20080113410
2008-05-15

Method for Rational Pegylation of Proteins

 #270
20080096819
2008-04-24

Amino acid substituted molecules

 #271
20080076729
2008-03-27

Interferon-beta gene therapy using an improved, regulated expression system

 #272
20080076706
2008-03-27

Derivatives of Growth Hormone and Related Proteins, and Methods of Use Thereof

 #273
20080050339
2008-02-28

Stable liquid interferon formulations

 #274
20080050338
2008-02-28

Stable liquid interferon-beta formulations

 #275
20080044381
2008-02-21

Stable liquid interferon formulations

 #276
20080038224
2008-02-14

Modified interferon-beta (IFN-beta) polypeptides

 #277
20080003202
2008-01-03

Modified interferon-beta (IFN-beta) polypeptides

 #278
20070259815
2007-11-08

Albumin fusion proteins

 #279
20070259405
2007-11-08

Optimized interferon-beta gene

 #280
20070244047
2007-10-18

Albumin fusion proteins

 #281
20070172928
2007-07-26

Immunoglobulin chimeric monomer-dimer hybrids

 #282
20070123697
2007-05-31

Process for purifying interferon beta

 #283
20070093649
2007-04-26

Process for purifying interferon beta

 #284
20070066813
2007-03-22

Modified transferrin fusion proteins

 #285
20070050855
2007-03-01

Modified transferrin fusion proteins

 #286
20070027305
2007-02-01

Method and system for in vitro protein folding

 #287
20070027068
2007-02-01

Erythropoietin: remodeling and glycoconjugation of erythropoietin

 #288
20070015253
2007-01-18

Latent fusion protein

 #289
20060292609
2006-12-28

Interferon-beta gene therapy using an improved, regulated expression system

 #290
20060287223
2006-12-21

Remodeling and glycoconjugation of peptides

 #291
20060276396
2006-12-07

Albumin fusion proteins

 #292
20060269516
2006-11-30

Interferon-IgG fusion

 #293
20060260002
2006-11-16

Nucleotide sequences for regulating gene expression in plant trichomes and constructs and methods utilizing same

 #294
20060246034
2006-11-02

Interferon-β complex

 #295
20060228332
2006-10-12

Fc-interferon-beta fusion proteins

 #296
20060204473
2006-09-14

Hyperglycosylated polypeptide variants and methods of use

 #297
20060194735
2006-08-31

Albumin fusion proteins

 #298
20060130158
2006-06-15

Modified transferrin fusion proteins comprising duplicate transferrin amino or carboxy terminal domains

 #299
20060120998
2006-06-08

Deamidated interferon-β

 #300
20060093579
2006-05-04

Human recombinant beta-interferon with improved solubility